ArticleThe Journal of clinical endocrinology and metabolism2026
Association between over- and under-replacement with thyroid hormone and incident heart failure.
Article in The Journal of clinical endocrinology and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
contextWhether over- or under-replacement with thyroid hormone is associated with incident heart failure remains unclear.
objectiveElucidate the relationship between thyroid hormone over- and under-replacement and incident heart failure.
designRetrospective cohort study of 641 504 adults who initiated thyroid hormone treatment between 2004 and 2017 at the Veterans Health Administration. Two cohorts of adults aged ≥18 years treated with thyroid hormone were separately studied: 638 323 adults with at least 2 outpatient thyroid stimulating hormone (TSH) measurements, and 338 249 adults with at least 2 outpatient free thyroxine (FT4) measurements, between thyroid hormone initiation and incident heart failure or study conclusion. Associations between time-varying TSH and FT4 exposure and incident heart failure as the outcome were analyzed.
resultsOverall, 564 152/641 504 (87.9%) patients were men. Median age was 66 years. Incident heart failure occurred in 81 286/641 504 (12.7%) patients. Following adjustment for age, sex, and cardiovascular risk factors (eg, smoking, hypertension), under-replacement (eg, TSH > 20 mIU/L, adjusted odds ratio [AOR], 1.93, 95% CI, 1.84-2.02; FT4 < 0.7 ng/dL, AOR 1.08; 95% CI, 1.04-1.12) and over-replacement (eg, TSH < 0.1 mIU/L, AOR, 1.06; 95% CI, 1.01-1.12; FT4 > 1.9 ng/dL, AOR, 1.23; 95% CI, 1.14-1.32) were associated with increased incident heart failure compared to euthyroidism. Incident heart failure risk was cumulative over time with both thyroid hormone over- and under-replacement, but association was strongest with under-replacement (eg, TSH > 5.5 mIU/L associated with a 5.8-fold increase in incident heart failure over 5 years).
conclusionOur findings suggest that thyroid hormone treatment intensity may be a modifiable risk factor for heart failure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.